Japan’s ruling coalition sustained a crushing blow in the Lower House election last month, only managing to win 215 seats,…
HOME > REGULATORY
REGULATORY
- Mix of Differential Pricing and Generic Drug Use Promotion Policies Can Help Reduce Drug Expenditure: Prof. Sakamaki
July 23, 2012
- MHLW Study Group Launches Info Website on Epilepsy Treatment Facilities
July 23, 2012
- Vaccines Are Good Investments: Dr Warton of CDC
July 23, 2012
- Industry Representatives Express Concern over Large Reductions in Prices of Long-Listed Drugs at CSIMC
July 20, 2012
- Industry Figures Stress Positive Impact of Premium for Generic-Name Prescribing at CSIMC
July 20, 2012
- Cost-Effective Assessments to Be Limited to Technologies for Which Alternatives Are Available: CSIMC
July 19, 2012
- PAFSC’s 2nd Committee on Drugs to Review 2 Combination DPT-IPV Vaccines on July 20
July 19, 2012
- Establishment of Relief System for Victims of Health Damage Due to Anticancer Drugs Should Be Put Off: MHLW Study Group
July 17, 2012
- Draft Revitalization Strategy Calls for Screening of 100 Drug Seeds through Drug Discovery Support Network by FY2015
July 13, 2012
- PFSB Calls for Revisions of Package Inserts for 13 Products Including Ranmark, Lyrica
July 13, 2012
- Gov’t to Discuss Expansion of Japan-EC Mutual Recognition Agreement in Pharmaceutical Sector
July 12, 2012
- Health Minister Komiyama Takes Lead to Include Reference Price Systems in Policy-Screening Group’s Proposals
July 10, 2012
- MHLW’s Medical Innovation Promotion Office Sets Up Cross-Sectional Task Forces to Discover Innovative Anticancer Drugs
July 10, 2012
- Bill Payers, Healthcare Providers Fighting over Financial Resources from Price Cuts for Long-listed Drugs
July 10, 2012
- PAFSC Second Committee to Review Products Including Novartis’s Pulmonary Infection Treatment on July 20
July 10, 2012
- Council’s Action Plan for FY2013 Calls for Conducting 10 Kinds of Clinical Trials within 5 Years
July 9, 2012
- On-Site Strategy Consultations to Be Held in Kansai Region: MHLW
July 6, 2012
- Interest Shown in Development of 3 Unapproved Drugs/Indications Including Metyrosine
July 6, 2012
- PMDA to Use Science Committee to Help Strengthen Review System: Executive Director Utsumi
July 5, 2012
- MHLW Approves 2 APIs Including Switch OTC Version of Allegra
July 5, 2012
ページ
For over two decades, Morunda has been at the forefront of interviewing and understanding leaders within Japan’s dynamic healthcare industry, particularly in pharmaceuticals and medical devices. What sets apart successful country managers in this competitive arena isn’t just their professional…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…